BackUniverse Pharmaceuticals INC Overview

Universe Pharmaceuticals INC Cost of Revenue

Cost of Revenue analysis for UPC.

Quarterly Cost of Revenue

$5.57M
23.84% YoY

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$28.51M
29.93% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)